David Graykowski
Impact in
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Tryptophan and brain disorders
Papers in
-
- Neuroinflammation and Neurodegeneration Mechanisms 4
-
- Alzheimer's disease research and treatments 4
- Co-authors
- Jeffrey N. Savas (1 shared paper)Morgan Sheng (2 shared papers)Arun Upadhyay (1 shared paper)Yizhi Wang (1 shared paper)Eiron Cudaback (2 shared papers)Lucia Giannini (1 shared paper)Borislav Dejanovic (1 shared paper)Jiechao Zhou (1 shared paper)
- Journals
- iScience (1 paper)Science Translational Medicine (1 paper)PLoS Biology (1 paper)Science Advances (1 paper)Cell (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
David Graykowski
8 papers receiving 164 citations
Peers
Comparison fields: 5 of 53
- Neurology 68
- Biological Psychiatry 12
- Developmental Neuroscience 18
- Physiology 54
- Cellular and Molecular Neuroscience 33
Countries citing papers authored by David Graykowski
This map shows the geographic impact of David Graykowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Graykowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Graykowski more than expected).
Fields of papers citing papers by David Graykowski
This network shows the impact of papers produced by David Graykowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Graykowski. The network helps show where David Graykowski may publish in the future.
Co-authors
The 25 scholars most cited alongside David Graykowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 69 | |
| 2 | 2020 | 31 | |
| 3 | 2024 | 21 | |
| 4 | 2022 | 17 | |
| 5 | 2021 | 12 | |
| 6 | 2025 | 7 | |
| 7 | 2020 | 6 | |
| 8 | 2025 | 2 |
About David Graykowski
David Graykowski is a scholar working on Neurology, Physiology, Cellular and Molecular Neuroscience, Cognitive Neuroscience and Molecular Biology, having authored 8 papers that have together received 165 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Neuroscience and Neural Engineering (2 papers), Photoreceptor and optogenetics research (2 papers), Neural dynamics and brain function (2 papers), interferon and immune responses (1 paper), MicroRNA in disease regulation (1 paper) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Neurology (68 citations), Biological Psychiatry (12 citations), Developmental Neuroscience (18 citations), Physiology (54 citations) and Cellular and Molecular Neuroscience (33 citations). David Graykowski has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Jeffrey N. Savas, Morgan Sheng, Arun Upadhyay, Yizhi Wang, Eiron Cudaback, Lucia Giannini, Borislav Dejanovic, Jiechao Zhou, John C. van Swieten and Mei-Fang Xiao. Their work appears in journals such as iScience, Science Translational Medicine, PLoS Biology, Science Advances and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.